Integral Diagnostics Limited
IDX.AX
#7132
Rank
$0.55 B
Marketcap
$1.49
Share price
3.48%
Change (1 day)
-1.64%
Change (1 year)

P/E ratio for Integral Diagnostics Limited (IDX.AX)

P/E ratio at the end of 2025: 234

According to Integral Diagnostics Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 140.73. At the end of 2025 the company had a P/E ratio of 234.

P/E ratio history for Integral Diagnostics Limited from 2016 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2025234-1750.08%
2024-14.2-134.22%
202341.4-26.83%
202256.645.97%
202138.8-2.02%
202039.644.99%
201927.3-14.58%
201832.0104.7%
201715.6-12.02%
201617.7

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.